Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.47)
# 3,505
Out of 5,043 analysts
173
Total ratings
45.21%
Success rate
-1.28%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $5.17 | -22.63% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $94.13 | +13.67% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $182.71 | -19.54% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $103.12 | -7.87% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $551.25 | +17.91% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.07 | -14.71% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $132.45 | -28.27% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $76.10 | +11.70% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $44.74 | -66.47% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $325.80 | +5.28% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.56 | +797.44% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $23.17 | +107.16% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $80.82 | +26.21% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $102.43 | -43.38% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.37 | +30.12% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $70.63 | +85.47% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $127.18 | +4.58% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $383.72 | -42.67% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $132.55 | +185.18% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $5.17
Upside: -22.63%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $94.13
Upside: +13.67%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $182.71
Upside: -19.54%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $103.12
Upside: -7.87%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $551.25
Upside: +17.91%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.07
Upside: -14.71%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $132.45
Upside: -28.27%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $76.10
Upside: +11.70%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $44.74
Upside: -66.47%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $325.80
Upside: +5.28%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.56
Upside: +797.44%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $23.17
Upside: +107.16%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $80.82
Upside: +26.21%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $102.43
Upside: -43.38%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.37
Upside: +30.12%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $70.63
Upside: +85.47%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $127.18
Upside: +4.58%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $383.72
Upside: -42.67%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $132.55
Upside: +185.18%